Nomura Holdings
ATRA icon

Nomura Holdings’s Atara Biotherapeutics ATRA Stock Holding History

Nomura Holdings’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,024
Closed -$243K – 1810
2022
Q1 		$243K Buy
1,024
+23
+2% +$7.32K ﹤0.01% 1519
2021
Q4 		$394K Sell
1,001
-23
-2% -$9.68K ﹤0.01% 1598
2021
Q3 		$449K Hold
1,024
– – ﹤0.01% 1467
2021
Q2 		$398K Hold
1,024
– – ﹤0.01% 1468
2021
Q1 		$368K Buy
1,024
+120
+13% +$53K ﹤0.01% 1453
2020
Q4 		$444K Hold
904
– – ﹤0.01% 1259
2020
Q3 		$292K Buy
904
+320
+55% +$109K ﹤0.01% 1123
2020
Q2 		$212K Buy
+584
New +$148K ﹤0.01% 991

Other funds holding ATRA

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Nomura Holdings's ATRA Position: Q2 2022 in Review

Nomura Holdings sold out of Atara Biotherapeutics (ATRA) in Q2 2022, closing a stake of 1,024 shares — an estimated $243K sold.

Nomura Holdings first reported a position in ATRA in Q2 2020 and held it in 8 quarters. The position peaked at $449K in Q3 2021. 134 funds tracked by Wall St. Rank hold ATRA as of Q2 2022.

  • Nomura Holdings reported no remaining Atara Biotherapeutics position as of Q2 2022 after selling out during the quarter.
  • Nomura Holdings sold 1,024 Atara Biotherapeutics shares in Q2 2022, an estimated $243K.
  • Nomura Holdings first reported a position in Atara Biotherapeutics in Q2 2020 and held it in 8 quarters.
  • Nomura Holdings's Atara Biotherapeutics position peaked at $449K in Q3 2021.
  • 134 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2022.

Based on Nomura Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.